Let's cut to the chase. The share price is down as the Daxxify aesthetics launch and guidance has been less than the market anticipated. Comparing today's share price to the highs last January 2023 is beyond comical but that's what average investors do... Is today's price correct or was the high last January incorrect? Most of us would agree both are/were wrong and I feel bad for those who bought the highs. With respect to your cash flow to equity, nobody trying to ramp a business with significant growth potential is focused on cash flow to equity, nor should they be. Your previous sky-is-falling post essentially talked about RVNC not generating free cash flows to pay off its principal debt / convertibles... Free cash flow doesn't need to pay off the principal debt balance (i.e., debt gets rolled everyday in this world). Foley's mission is to ramp sales over the next 18-24 months, and package the company for sale. Everyone can do math and come up with their own estimate of EV in 2026, back out debt to arrive at what equity might be worth in a take-out scenario.
First, Therapeutics and Aesthetics are night and day different. Second, the current share price isn't pricing in Dew's expectations (actually nothing in the ball-park). Third, understanding the risks of all investments is important, however, your posts seem to say you're way over your ski's (cannot handle risk) and you should be invested in some steady-eddy investments. If you cannot handle the volatility / risks, or if you don't have the confidence in the Company's ability to execute / drive shareholder value over the next 18-24 months ---- sell and invest in something else. It's that simple.
IMO, Foley will make a sizable ($500k+) open-market purchase after RVNC fully releases earnings.